SYROS PHARMACEUTICALS, INC. Operating Expenses
SYROS PHARMACEUTICALS, INC. reported Operating Expenses of $26.18 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2024-10-31
- SYROS PHARMACEUTICALS, INC. operating expenses for the quarter ending 2024-09-30 was $26.18M, a 31.81% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. operating expenses for the quarter ending 2024-06-30 was $27.42M, a 25.57% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. operating expenses for the quarter ending 2024-03-31 was $30.92M, a 14.50% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. operating expenses for the quarter ending 2023-12-31 was $27.53M, a 21.90% decline year-over-year.
- SYROS PHARMACEUTICALS, INC. operating expenses for fiscal 2023 was $138.92M, a 7.85% decline from fiscal 2022.
- SYROS PHARMACEUTICALS, INC. operating expenses for fiscal 2022 was $150.75M, a 22.66% increase from fiscal 2021.
- SYROS PHARMACEUTICALS, INC. operating expenses for fiscal 2021 was $122.91M, a 26.20% increase from fiscal 2020.
- SYROS PHARMACEUTICALS, INC. operating expenses for fiscal 2020 was $97.39M, a 22.16% increase from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2024-09-30 | $26.18M 10-Q · filed 2024-10-31 | $53.60M derived: sum of 2 quarters · filed 2024-10-31 | $84.52M 10-Q · filed 2024-10-31 | $112.05M derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-06-30 | $27.42M 10-Q · filed 2024-07-31 | $58.34M 10-Q · filed 2024-07-31 | $85.86M derived: sum of 3 quarters · filed 2024-07-31 | $124.26M derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-03-31 | $30.92M 10-Q · filed 2024-05-14 | $58.45M derived: sum of 2 quarters · filed 2024-05-14 | $96.84M derived: sum of 3 quarters · filed 2024-10-31 | $133.68M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-12-31 | $27.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $65.92M derived: sum of 2 quarters · filed 2024-10-31 | $102.76M derived: sum of 3 quarters · filed 2024-10-31 | $138.92M 10-K · filed 2024-03-27 |
| 2023-09-30 | $38.40M 10-Q · filed 2024-10-31 | $75.23M derived: sum of 2 quarters · filed 2024-10-31 | $111.40M 10-Q · filed 2024-10-31 | $146.64M derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $36.83M 10-Q · filed 2024-07-31 | $73.00M 10-Q · filed 2024-07-31 | $108.24M derived: sum of 3 quarters · filed 2024-07-31 | $151.59M derived: sum of 4 quarters · filed 2024-07-31 |
| 2023-03-31 | $36.17M 10-Q · filed 2024-05-14 | $71.41M derived: sum of 2 quarters · filed 2024-05-14 | $114.75M derived: sum of 3 quarters · filed 2024-05-14 | $154.80M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $35.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $78.59M derived: sum of 2 quarters · filed 2024-03-27 | $118.63M derived: sum of 3 quarters · filed 2024-03-27 | $150.75M 10-K · filed 2024-03-27 |
| 2022-09-30 | $43.34M 10-Q · filed 2023-11-14 | $83.39M derived: sum of 2 quarters · filed 2023-11-14 | $115.51M 10-Q · filed 2023-11-14 | $148.74M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $40.05M 10-Q · filed 2023-08-08 | $72.17M 10-Q · filed 2023-08-08 | $105.39M derived: sum of 3 quarters · filed 2023-08-08 | $138.00M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $32.12M 10-Q · filed 2023-05-10 | $65.34M derived: sum of 2 quarters · filed 2023-05-10 | $97.95M derived: sum of 3 quarters · filed 2023-05-10 | $129.26M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $33.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $65.83M derived: sum of 2 quarters · filed 2023-03-02 | $97.14M derived: sum of 3 quarters · filed 2023-03-02 | $122.91M 10-K · filed 2023-03-02 |
| 2021-09-30 | $32.61M 10-Q · filed 2022-11-14 | $63.91M derived: sum of 2 quarters · filed 2022-11-14 | $89.68M 10-Q · filed 2022-11-14 | $124.60M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $31.31M 10-Q · filed 2022-08-09 | $57.08M 10-Q · filed 2022-08-09 | $91.99M derived: sum of 3 quarters · filed 2022-08-09 | $114.82M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $25.77M 10-Q · filed 2022-05-16 | $60.69M derived: sum of 2 quarters · filed 2022-05-16 | $83.51M derived: sum of 3 quarters · filed 2022-05-16 | $103.44M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $34.92M 10-K · filed 2021-03-04 | $57.74M derived: sum of 2 quarters · filed 2021-11-05 | $77.67M derived: sum of 3 quarters · filed 2021-11-05 | $97.39M 10-K · filed 2023-03-02 |
| 2020-09-30 | $22.82M 10-Q · filed 2021-11-05 | $42.75M derived: sum of 2 quarters · filed 2021-11-05 | $62.47M 10-Q · filed 2021-11-05 | $83.15M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $19.93M 10-Q · filed 2021-08-05 | $39.65M 10-Q · filed 2021-08-05 | $60.33M derived: sum of 3 quarters · filed 2021-08-05 | $81.27M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $19.72M 10-Q · filed 2021-05-06 | $40.40M derived: sum of 2 quarters · filed 2021-05-06 | $61.34M derived: sum of 3 quarters · filed 2021-05-06 | $82.01M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $20.68M 10-K · filed 2021-03-04 | $41.63M derived: sum of 2 quarters · filed 2021-03-04 | $62.30M derived: sum of 3 quarters · filed 2021-03-04 | $79.72M 10-K · filed 2022-03-15 |
| 2019-09-30 | $20.95M 10-K · filed 2021-03-04 | $41.62M derived: sum of 2 quarters · filed 2021-03-04 | $59.05M 10-Q · filed 2020-11-05 | $78.54M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $20.67M 10-K · filed 2021-03-04 | $38.10M 10-Q · filed 2020-08-06 | $57.60M derived: sum of 3 quarters · filed 2021-03-04 | $74.33M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $17.43M 10-K · filed 2021-03-04 | $36.93M derived: sum of 2 quarters · filed 2021-03-04 | $53.66M derived: sum of 3 quarters · filed 2021-03-04 | $68.58M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | $19.50M 10-K · filed 2020-03-05 | $36.23M derived: sum of 2 quarters · filed 2020-03-05 | $51.16M derived: sum of 3 quarters · filed 2020-03-05 | $66.35M 10-K · filed 2021-03-04 |
| 2018-09-30 | $16.73M 10-K · filed 2020-03-05 | $31.66M derived: sum of 2 quarters · filed 2020-03-05 | $46.85M 10-Q · filed 2019-11-12 | $62.37M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | $14.92M 10-K · filed 2020-03-05 | $30.11M 10-Q · filed 2019-08-01 | $45.63M derived: sum of 3 quarters · filed 2020-03-05 | $59.67M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | $15.19M 10-K · filed 2020-03-05 | $30.71M derived: sum of 2 quarters · filed 2020-03-05 | $44.75M derived: sum of 3 quarters · filed 2020-03-05 | $58.26M derived: sum of 4 quarters · filed 2020-03-05 |
| 2017-12-31 | $15.52M 10-K · filed 2019-03-07 | $29.56M derived: sum of 2 quarters · filed 2019-03-07 | $43.07M derived: sum of 3 quarters · filed 2019-03-07 | $55.79M 10-K · filed 2020-03-05 |
| 2017-09-30 | $14.04M 10-K · filed 2019-03-07 | $27.55M derived: sum of 2 quarters · filed 2019-03-07 | $40.27M 10-Q · filed 2018-11-01 | $51.63M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $13.51M 10-K · filed 2019-03-07 | $26.23M 10-Q · filed 2018-08-07 | $37.59M derived: sum of 3 quarters · filed 2019-03-07 | $51.81M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $12.71M 10-K · filed 2019-03-07 | $24.08M derived: sum of 2 quarters · filed 2019-03-07 | $38.29M derived: sum of 3 quarters · filed 2019-03-07 | $50.36M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $11.36M 10-K · filed 2018-03-12 | $25.58M derived: sum of 2 quarters · filed 2018-03-12 | $37.64M derived: sum of 3 quarters · filed 2018-03-12 | $48.28M 10-K · filed 2019-03-07 |
| 2016-09-30 | $14.22M 10-K · filed 2018-03-12 | $26.28M derived: sum of 2 quarters · filed 2018-03-12 | $36.92M 10-Q · filed 2017-11-08 | $47.61M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $12.06M 10-K · filed 2018-03-12 | $22.70M 10-Q · filed 2017-08-09 | $33.39M derived: sum of 3 quarters · filed 2018-03-12 | $41.85M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $10.64M 10-K · filed 2018-03-12 | $21.32M derived: sum of 2 quarters · filed 2018-03-12 | $29.79M derived: sum of 3 quarters · filed 2018-03-12 | $36.20M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $10.69M 10-K · filed 2017-03-20 | $19.15M derived: sum of 2 quarters · filed 2017-03-20 | $25.57M derived: sum of 3 quarters · filed 2017-03-20 | $30.14M 10-K · filed 2018-03-12 |
| 2015-09-30 | $8.46M 10-K · filed 2017-03-20 | $14.88M derived: sum of 2 quarters · filed 2017-03-20 | $19.45M 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $6.41M 10-K · filed 2017-03-20 | $10.98M 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $4.57M 10-K · filed 2017-03-20 | |||
| 2014-12-31 | $13.44M 10-K · filed 2017-03-20 |